Logo

Nora Signs an Exclusive Agreement Biopharmaceutical Partner to Launch a Biosimilar in Canada

Share this

Nora Signs an Exclusive Agreement Biopharmaceutical Partner to Launch a Biosimilar in Canada

Shots:

  • Nora collaborates with a biopharmaceutical partner to obtain the commercial rights for a biosimilar drug
  • The collaboration will support both private insurers and public formularies by reducing the costs of biosimilars & provide accessibility to patients for high quality affordable pharmaceutical products
  • Nora Pharma's activities coordinate with the biosimilars transition policy adopted by several Canadian provinces

Ref: Newswire | Image: Stat News

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions